Obtain Medicare prospective payment system exemption for the Nevada Cancer Institute (no specific legislation)
Repeal and reform the formula used to calculate Medicare physician payments (no specific legislation)
H.R. 3590, the "Patient Protection and Affordable Care Act" -- lobbied on the following sections:
Sec. 3135, Modification of Medicare equipment utilization factor for advanced imaging servcies.
Sec. 5501, Expanding access to primary care services and general surgery services. Remove budget neutrality requirement
Sec. 10323, Medicare coverage for individuals exposed to environmental health hazards.
Sec. 3510, Patient navigator program
Sec. 4107, Coverage of comprehensive tobacco cessation services for pregnant women in Medicaid
Sec. 4104, Removal of barriers to preventive services in Medicare
H.R. 3962, the "Affordable Health Care for America Act." -- lobbied on the following sections:
Sec. 1146, Payment for imaging services
Sec. 1712, Tobacco cessation
Sec. 1306, Waiver of deductible for colorectal cancer screening tests regardless of coding, subsequent diagnosis, or ancillary tissue removal
H.R. 3590, the "Patient Protection and Affordable Care Act" -- lobbied on the following sections:
Sec. 10103, Increases patient access to clinical trials and studies, including cancer clinical trials.
Sec. 10413, Young women's breast health awareness and support of young women diagnosed with breast cancer
Sec. 10408, Grants for small businesses to provide comprehensive workplace wellness programsH.R. 3590, the "Patient Protection and Affordable Care Act" -- lobbied on the following sections (cont.):
Sec. 9007, Additional requirements for charitable hospitals
H.R. 3962, the "Affordable Health Care for America Act." -- lobbied on the following sections:
Sec. 1303, Payment incentive for selected primary care services. Remove budget neutrality.
Sec. 112, Wellness program grants
H.R. 1189, the "Colorectal Cancer Prevention, Early Detection and Treatment Act of 2009" - advocated introduction in of companion legislation in the Senate.
Duration: February 15, 2008
to
July 20, 2010
General Issues: Medicare/Medicaid , Health Issues , Budget/Appropriations , Medical/Disease Research/Clinical Labs , Natural Resources , Environmental/Superfund , Tobacco
Spending: about $271,273 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2008: House of Representatives, U.S. Senate, U.S. Senate,
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
2nd Quarter, 2010
Nevada Cancer Institute in-house lobbying effort was terminated on July 20, 2010
Original Filing: 300304012.xml
1st Quarter, 2010
In Q1, Nevada Cancer Institute had in-house lobbyists. The report was filed on April 20, 2010.
Original Filing: 300275352.xml
Lobbying Issues
Obtain Medicare prospective payment system exemption for the Nevada Cancer Institute (no specific legislation)
Repeal and reform the formula used to calculate Medicare physician payments (no specific legislation)
H.R. 3590, the "Patient Protection and Affordable Care Act" -- lobbied on the following sections:
Sec. 3135, Modification of Medicare equipment utilization factor for advanced imaging servcies.
Sec. 5501, Expanding access to primary care services and general surgery services. Remove budget neutrality requirement
Sec. 10323, Medicare coverage for individuals exposed to environmental health hazards.
Sec. 3510, Patient navigator program
Sec. 4107, Coverage of comprehensive tobacco cessation services for pregnant women in Medicaid
Sec. 4104, Removal of barriers to preventive services in Medicare
H.R. 3962, the "Affordable Health Care for America Act." -- lobbied on the following sections:
Sec. 1146, Payment for imaging services
Sec. 1712, Tobacco cessation
Sec. 1306, Waiver of deductible for colorectal cancer screening tests regardless of coding, subsequent diagnosis, or ancillary tissue removal
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 3590, the "Patient Protection and Affordable Care Act" -- lobbied on the following sections:
Sec. 10103, Increases patient access to clinical trials and studies, including cancer clinical trials.
Sec. 10413, Young women's breast health awareness and support of young women diagnosed with breast cancer
Sec. 10408, Grants for small businesses to provide comprehensive workplace wellness programsH.R. 3590, the "Patient Protection and Affordable Care Act" -- lobbied on the following sections (cont.):
Sec. 9007, Additional requirements for charitable hospitals
H.R. 3962, the "Affordable Health Care for America Act." -- lobbied on the following sections:
Sec. 1303, Payment incentive for selected primary care services. Remove budget neutrality.
Sec. 112, Wellness program grants
H.R. 1189, the "Colorectal Cancer Prevention, Early Detection and Treatment Act of 2009" - advocated introduction in of companion legislation in the Senate.
Agencies Lobbied
U.S. Senate
4th Quarter, 2009
In Q4, Nevada Cancer Institute had in-house lobbyists. The report was filed on Jan. 20, 2010.
Original Filing: 300245930.xml
Lobbying Issues
- Support expansion of Medicare prospective payment system exemption to include the Nevada Cancer Institute
- S. 1776, "Medicare Physician Fairness Act of 2009"
- H.R. 3961, the Medicare Physician Payment Reform Act
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
- H.R. 3293, FY 2010 Labor, Health and Human Services and Education Appropriations Bill - Support inclusion of ($400,000-House / $500,000 - Senate) for cancer education and outreach services conducted by the Nevada Cancer Institute.
- H.R. 3326, FY2010 Defense Appropriations Bill - Support inclusion of funding ($2.5 million-House/$2 million Senate) for wound healing and tissue regeneration research and biomarker discovery.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
- Sen. Sherrod Brown Amendment #2871 to H.R. 3590, the Patient Protection and Affordable Care Act, which would require insurers to provide coverage for routine medical services provided in conjuncted with an approved clinical trial or study.
3rd Quarter, 2009
In Q3, Nevada Cancer Institute had in-house lobbyists. The report was filed on Oct. 20, 2009.
Original Filing: 300221389.xml
Lobbying Issues
H.R. 3200, "America's Affordable Health Choices Act of 2009"
- Support expansion of legislation to include Medicare prospective payment system exemption to the Nevada Cancer Institute
- Sec. I121, "Sustainable growth rate reform" - Support as writtenH.R. 3200 Continued...
- Sec. 1 147, "Payment for imaging services" - Oppose as written. Support modifications in the proposed utilization assumption
rates; Support removal of ultrasound from increases in the utilization assumption rate.
- Sec. 1712, "Tobacco Cessation" - Support as written
- Sec. 1306, "Waiver of deductible for colorectal cancer screening tests regardless of coding, subsequent diagnosis, or
anciallary tissue removal" - Support as written
- Sec. I142, "Extension of paynent rule for brachytherapy" - Support as written
"America's Health Future Act of 2009" (no Senate bill number)
- Lincoln Amendment #D-15 (Finance Committee Mark Up) - Support amendment which would expand Medicare prospective
payment system exemption to the Nevada Cancer Institute and three other cancer centers.
- Lincoln Amendment #D-1l (Finance Committee Mark Up) - Support amendment which would remove radiation therapy from
the provision increasing the equipment utilization assumption rate
- Grassley Amendment #F-8 (Finance Committee Mark Up) - Oppose amendment which would remove the rebuttable
presumption of resonableness for tax-exempt organizations.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 3293, FY 2010 Labor, Health and Human Services and Education Appropriations Bill - Support funding for the National
Institutes of Health and the National Cancer Institute; Support inclusion of ($400,000 -House/ $500,000-Senate) for cancer
education and outreach services conducted by the Nevada Cancer Institute.
H.R. 3326, FY20l0 Defense Appropriations Bill - Support inclusion of funding ($2.5 million - House/ $2 million Senate) for
wound healing and tissue regeneration research and biomarker discovery.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. - 3200, "America's Affordable Health Choices Act of 2009"- Oppose limiting the value of itemized deductions for charitable
contributions for the most affluent Americans. Support investments in prevention and wellnesss, specifically tax incentives for
workplace wellness programs.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2009
In Q2, Nevada Cancer Institute had in-house lobbyists. The report was filed on July 20, 2009.
Original Filing: 300193824.xml
Lobbying Issues
Health Care Reform Legislation: Coverage of Clinical Trials; Prevention and Wellness Incentives; Itemized Deductions for Charitable Donations; Tobacco Cessation; Waiver of Deductible for Colorectal Cancer Screening Tests; Payment for Brachytherapy and Therapeutic Radiopharmaceuticals.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Medicare Hospital PPS Exemption; Medical Imaging Reimbursement; Medicare Physician Reimbursement
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
FY 2010 Labor, Health and Education Appropriations Bills lobbied in support of funding $1 billion to the National Cancer Insutute and $3 billion to the National Institutees of Health.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2009
In Q1, Nevada Cancer Institute had in-house lobbyists. The report was filed on April 16, 2009.
Original Filing: 300152174.xml
Lobbying Issues
H.R. 1, the "American Recovery and Reinvestment Act"
Title VIII; Subtitle B Health and Human Services
National Institutes of Health, National Center for Research Resources, Agency for Healthcare Research and Quality (Comparative Effectiveness Research); Centers for Disease Control and Prevention (Prevention and Wellness Fund)Title VI - Medicare and Medicaid Health Information Technology; Miscellaneous Medicare Provisions
Subtitle A - Medicare Incentives; Sec.4101 - Incentives for Eligible Professionals
Title XXX - Health Information Technology and Quality
Subtitle D - Privacy; Part I - Improved Privacy Provisions and Security Provisions
Sec. 13406 - Conditions on Certain Contacts as Part of Health Care Operations; (b) Opportunity to Opt out of Fundraising
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Medicare physician payment formula; Stark self-referral laws; and Medicare payment policy for medical imaging. No specific bill numbers.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Access to cancer clinical trials; Incentives for Employer Wellness Programs; Health Reform Trust Fund Financing (oppose change in tax laws for charitable contributions). No specific bill numbers.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Support for a 20 percent funding increase for the National Cancer Institute for Fiscal Year 2010. No specific bill number.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
4th Quarter, 2008
In Q4, Nevada Cancer Institute had in-house lobbyists. The report was filed on Jan. 21, 2009.
Original Filing: 300132810.xml
Lobbying Issues
Lobbied in support for increased funding for medical research funding through the National Institutes of Health as part of 2009 economic stimulus legislation
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Lobbied in support of including the following for inclusion in a 2009 economic stimulus bill: (1) Medicare prospective payment system exemption for a future hospital affiliated with the Nevada Cancer Institute; and (2) increased Medicaid funding to states.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2008
Nevada Cancer Institute amended a lobbying report for in-house lobbying in Q32008 on May 8, 2009
Original Filing: 300168872.xml
Lobbying Issues
H.R. 3161, the "Childrens Health and Medicare Protection Act of 2007;" Sec. 505 "PPS Exempt Hospitals." Lobbied in support of adding a future cancer hospital affiliated with the Nevada Cancer Institute to the list of Medicare inpatient prospective payment system exempt cancer hospitals.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 1108, the "Family Smoking Prevention and Tobacco Control Act"
S. 2999, the "Access to Cancer Clinical Trials Act of 2008"
H.R. 6791, the "National Cancer Fund Act of 2008"
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 2638, the "Consolidated Security, Disaster Assistance, and Continuing Appropriations Act of 2009." Lobbied in support for increased funding for the National Institute of Health and the Centers for Disease Control and Prevention.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2008
In Q3, Nevada Cancer Institute had in-house lobbyists. The report was filed on Oct. 20, 2008.
Original Filing: 300107202.xml
Lobbying Issues
H.R. 3161, the "Childrens Health and Medicare Protection Act of 2007;" Sec. 505 "PPS Exempt Hospitals." Lobbied in support of adding a future cancer hospital affiliated with the Nevada Cancer Institute to the list of Medicare inpatient prospective payment system exempt cancer hospitals.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 1108, the "Family Smoking Prevention and Tobacco Control Act"
S. 2999, the "Access to Cancer Clinical Trials Act of 2008"
H.R. 6791, the "National Cancer Fund Act of 2008"
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 2638, the "Consolidated Security, Disaster Assistance, and Continuing Appropriations Act of 2009." Lobbied in support for increased funding for the National Institute of Health and the Centers for Disease Control and Prevention.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2008
In Q2, Nevada Cancer Institute had in-house lobbyists. The report was filed on July 18, 2008.
Original Filing: 300074410.xml
Lobbying Issues
H.R. 3161, the "Childrens Health and Medicare Protection Act of 2007," Sec. 505 "PPS Exempt Hospitals"; Lobbying in support of adding a future cancer hospital affiliated with the Nevada Cancer Institute to the list of Medicare inpatient prospective payment system exempt cancer hospitals.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S. 742, the "Ban Asbestos in America Act of 2007," lobbied in support of Section 4 supporting research for mesothelioma.
Lobbying Issues
H.R. 2642, the "supplemental Appropriations Act of 2008, "Lobbied in support of funding for the National Institutes of Health.
FY 2009 Labor, Health and Education Appropriations (no bill numbers). Lobbied in support of increased funding for the National Institutes of Health (6.5% increase), the National Cancer Institute (9.5% increase).
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S758 and HR 1311 The Nevada Cancer Institute Expansion Act
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2008
In Q2, Nevada Cancer Institute had in-house lobbyists. The report was filed on April 21, 2008.
Original Filing: 300054628.xml
Lobbying Issues
S758 and HR1311 The Nevada Cancer Institute Expansion Act
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
HR 3162 The Children's Health and Medicare Protection Act of 2007 - Section 505 "PPS Exempt Hospitals" ; S2785 The Save Medicare Act of 2008, Section 2 "Increase in Medicare Physician Payment Update"; Lobbying in support of adding a future cancer hospital affiliated with the Nevada Cancer Institute to the list of Medicare in-patient prospective payment system exempt cancer hospitals; Lobbying in support of preventing cuts in Medicare physician payments in 2008 and 2009
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S579 The Breast Cancer and Environmental Research Act of 2007
Lobbying Issues
SCONRES 70 The Fiscal Year 2009 Senate Budget Resolution in support of amendment offered by Senator Tom Harkin and Senator Arlen Specter that would increase spending to the National Institutes of Health by three billion. Lobby in support of a 10.3 percent increase to the National Institutes of Health for fiscal year 2009 and for a 9.5 percent increase to the National Cancer Institute for fiscal year 2009
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2008
In Q1, Nevada Cancer Institute had in-house lobbyists. The report was filed on Feb. 24, 2009.
Original Filing: 300138979.xml
Lobbying Issues
S78 and HR1311 The Nevada Cancer Institute Expansion Act
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
HR 3162 The Children's Health and Medicare Protection Act of 2007 - Section 505 "PPS Exempt Hospitals"; S 2785 The Save Medicare Act of 2008, Section 2 "Increase in Medicare Physician Payment Update"; Lobbying in support of adding a future cancer hospital affiliated with the Nevada Cancer Institute to the list of Medicare in-patient prospective payment system exempt cancer hospitals; Lobbying in support of preventing cuts in Medicare physician payments in 2008 and 2009
Agencies Lobbied
U.S. Senate
Lobbying Issues
S579 The Breast Cancer and Environmental Research Act of 2007
Lobbying Issues
SCONRES 70 The Fiscal Year 2009 Senate Budget Resolution in support of amendment offered by Senator Tom Harkin and Senator Arlen Spector that would increase spending to the National Institutes of Health by three billion. Lobby in support of a 10.3 percent increase to the National Institutes of Health for fiscal year 2009 and for a 9.5 percent increase to the National Cancer Institute for fiscal year 2009.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2008
Nevada Cancer Institute filed a lobbying registration on April 6, 2008 for in-house lobbying efforts, effective Feb. 15, 2008.
Original Filing: 300033025.xml
Issue(s) they said they’d lobby about: NIH, DOD and DOE Appropriations; Medicare prospective payment system exemption; Tobacco regulations; Medicare payment; S758, HR1311, cancer prevention and awareness .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...